FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Lloyd Levothroid Recall

Levothroid (levothyroxine sodium tablets, USP), 75 mcg

Lloyd Inc · Shenandoah, IA

Risk level
Class II
Reported by FDA
Jul 4, 2012
Recall ID
D-1394-2012
Check your lot numberHow we source this data

Summary

Lloyd recalled Levothroid starting Feb 24, 2012. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1394-2012 on Jul 4, 2012. Reason: Subpotent (Single Ingredient Drug): Low assay at the 6-month test interval. Status: Terminated.

Why it was recalled

Subpotent (Single Ingredient Drug): Low assay at the 6-month test interval.

Product description

Levothroid (levothyroxine sodium tablets, USP), 75 mcg., 100-count bottles, Rx only, NDC 0456-1322-01, Manufactured for Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, MO, by Lloyd Pharmaceutical, Shenandoah, Iowa 51601

Lot numbers, UPCs & expiration codes

LOT NO.1092045

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1394-2012
Classification
Class II
Status
Terminated
Recall initiated
Feb 24, 2012
FDA report date
Jul 4, 2012
Quantity
19,039 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Lloyd Inc

Original FDA data

Every field from FDA enforcement report D-1394-2012, exactly as published.

Show all FDA fields
City
Shenandoah
State
IA
Status
Terminated
Country
United States
Event ID
61252
Address
604 W Thomas Ave
Code information
LOT NO.1092045
Postal code
51601-1744
Report date
Jul 4, 2012
Product type
Drugs
Recall number
D-1394-2012
Classification
Class II
Recalling firm
Lloyd Inc
Product quantity
19,039 bottles
Termination date
Jul 30, 2013
Reason for recall
Subpotent (Single Ingredient Drug): Low assay at the 6-month test interval.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Levothroid (levothyroxine sodium tablets, USP), 75 mcg., 100-count bottles, Rx only, NDC 0456-1322-01, Manufactured for Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, MO, by Lloyd Pharmaceutical, Shenandoah, Iowa 51601
Distribution pattern
Nationwide
Recall initiation date
Feb 24, 2012
Initial firm notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Center classification date
Jun 22, 2012

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1394-2012, published Jul 4, 2012. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls